Sort
78,016 grants matching “breast cancer”
A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning
$524,557Nancy E Avis · Wake Forest University Health Sciences · R01 · FY2016 · CA
Shared Resources Core-1: Integrated Clinical, Tissue, and Biomarker Data Base Core (ICTBD Core)
$524,556Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2018 · CA
Developing Selective EphA2 Inhibitors for the treatment of Cancer
$524,549Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Developing Selective EphA2 Inhibitors for the treatment of Cancer
$524,549Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2015 · CA
A prediction model to simultaneously estimate personal risk of breast cancer and death from other causes in women aged 55 and older
$524,548Mara A Schonberg · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Nanoparticle contrast agents for earlier breast cancer detection
$524,525David Peter Cormode · University Of Pennsylvania · R01 · FY2021 · CA
DEVELOPMENTAL FUNDS
$524,426John H. Glick · University Of Pennsylvania · P30 · FY2008 · CA
Molecular basis and targeting of FASN in expanding PARPi utility for TNBC
$524,419Jian-Ting Zhang · University Of Toledo Health Sci Campus · R01 · FY2025 · CA
Kalamazoo Community Clinical Oncology Program
$524,412Raymond S Lord · West Michigan Cancer Center · U10 · FY2012 · CA
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer
$524,410Ashutosh Agarwal · University Of Miami School Of Medicine · U01 · FY2022 · CA
Circulating Tumor Cell Capture & Analysis in a Multi-Center Prostate Cancer Trial
$524,400Richard James Cote · University Of Miami School Of Medicine · R01 · FY2009 · CA
Nanoparticle contrast agents for earlier breast cancer detection
$524,367David Peter Cormode · University Of Pennsylvania · R01 · FY2020 · CA
Adapting patient navigation to promote cancer screening in Chicagos Chinatown
$524,244Melissa A. Simon · Northwestern University At Chicago · R01 · FY2015 · CA
DEVELOPMENT OF NOVEL DRUGS FOR HIGH RISK TRIPLE NEGATIVE BREAST CANCER TREATMENT
$524,234Regents Of The University Of Minnesota · · FY2015 · Department of the Army
Neovascular-Direct Nanoparticles for Detection, Characterization, and Treatment
$524,194Gregory M Lanza · Washington University · U54 · FY2009 · CA
MRI-R2: Development of Hyperspectral Optical Property Instrumentation (HOPI) for Biomedical and Environmental Research
$524,171Mehrube Mehrubeoglu · Texas A&M University Corpus Christi · · FY2010 · ENG
Regulation of the Fanconi Anemia Pathway by Ubiquitination
$524,141Alan David D'andrea · Dana-Farber Cancer Inst · R01 · FY2012 · DK
Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy
$524,106Carri Kaye Glide-Hurst · University Of Wisconsin-Madison · R01 · FY2021 · HL
Cognition and Error Management for Critical Care
$524,072Columbia University Health Sciences · R01 · FY2004 · LM
Novel Strategy of PDE5-mTOR Inhibition in Attenuation of Cancer Drug Cardiotoxicity
$524,060Anindita Das · Virginia Commonwealth University · R01 · FY2025 · HL
Improving our understanding of breast cancer mortality disparities through recurrence: a multi-level approach among women in Georgia
$524,010Lauren E McCullough · Emory University · R01 · FY2024 · CA
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
$523,990Vanessa Bellat · Weill Medical Coll Of Cornell Univ · R37 · FY2025 · CA
Harmonization of breast MRI data
$523,960Maciej A. Mazurowski · Duke University · R01 · FY2023 · EB
Stem Cells and Perinatal Factors for Breast Cancer Risk
$523,937Univ Of Massachusetts Med Sch Worcester · R01 · FY2002 · CA
Shanghai Breast Cancer Study
$523,902Wei Zheng · Vanderbilt University · R01 · FY2010 · CA